Patents matching “treatment”

US 9402935

Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

Lutonix, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

US 9403911

Compositions and methods for detection and treatment of cancer

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 2, 2016 · Expires Jul 28, 2036

US 9402820

Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

US 9399034

Methods of sedation during critical care treatment

OVID THERAPEUTICS INC. · Granted Jul 26, 2016 · Expires Jul 21, 2036

US 9399648

Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2016 · Expires Jul 21, 2036

US 9393271

GHRH agonists for islet cell transplantation and function and the treatment of diabetes

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 19, 2016 · Expires Jul 14, 2036

US 9394359

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

China Synthetic Rubber Corporation · Granted Jul 19, 2016 · Expires Jul 14, 2036

US 9387224

Treatment of specific cardiovascular conditions with nitrite

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

US 9388163

Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 12, 2016 · Expires Jul 7, 2036

US 2016185873

MONOCLONAL ANTIBODIES FOR TREATMENT OF CANCER

GANYMED PHARMACEUTICALS AG [DE] · Granted Jun 30, 2016 · Expires Jun 25, 2036

US 9375475

Combination immunotherapy for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Jun 28, 2016 · Expires Jun 23, 2036

US 9370527

Amelioration of intestinal fibrosis and treatment of Crohn's disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 21, 2016 · Expires Jun 16, 2036

US 9364448

Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

US 9364501

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

US 9364505

Therapeutic composition for treatment of glioblastoma

Regents of the University of Minnesota · Granted Jun 14, 2016 · Expires Jun 9, 2036

US 9359290

Treatment of cataplexy

Jazz Pharmaceuticals International III Limited · Granted Jun 7, 2016 · Expires Jun 2, 2036

US 9358249

Use of Pateamine A for the treatment of age-related muscle wasting

The Regents of the University of California · Granted Jun 7, 2016 · Expires Jun 2, 2036

US 9351989

Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

University College Cardiff Consultants Limited · Granted May 31, 2016 · Expires May 26, 2036

US 9352019

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

University of Connecticut Health Center · Granted May 31, 2016 · Expires May 26, 2036

US 9351960

Agent for the treatment of viral hepatitis C

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted May 31, 2016 · Expires May 26, 2036

PH 12016500580

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

OXFORD BIOTHERAPEUTICS LTD [GB] · Granted May 30, 2016 · Expires May 25, 2036

US 9340782

Antimir-451 for the treatment of polycythemias

The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

US 9339515

Method for treatment of pulmonary fibrosis

GALECTIN THERAPEUTICS, INC. · Granted May 17, 2016 · Expires May 12, 2036

US 9339491

Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease

MEREO BIOPHARMA 1 LIMITED · Granted May 17, 2016 · Expires May 12, 2036